MedPath

Gastric conduit perfusion assessment by indocyanine green fluorescent imaging in minimally invasive esophagectomy; an exploratory study

Completed
Conditions
esophageal cancer
esophageal carcinoma
10017998
Registration Number
NL-OMON45919
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
9
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:
* All patients eligible for minimally invasive esophagectomy for easophageal cancer, with gastric conduit reconstruction and intrathoracic gastro-esophageal anastomosis
* Aged 18 years or older
* Providing informed consent

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in the study:
* Known Liver or renal insufficiency
* Known pregnancy or breastfeeding
* Known iodine, shellfish or ICG hypersensitivity
* Unable to provide informed consent

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To explore the feasibility and added value of NIRF to assess gastric conduit<br /><br>perfusion in minimally invasive esophagectomy. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Indentify the increase in procedure time </p><br>
© Copyright 2025. All Rights Reserved by MedPath